Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.2 TWD
65.35 M TWD
810.92 M TWD
15.37 M
About TSH BIOPHARM CORPORATION LIMITED
Sector
CEO
Ssu Yuan Yang
Headquarters
Taipei
Website
Founded
2010
ISIN
TW0008432006
FIGI
BBG001QYZ3H1
TSH Biopharm Corp., Ltd. engages in the provision of biotechnology services and sale of pharmaceuticals and chemical drugs. The company was founded on September 1, 2010 and is headquartered in Taipei, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 8432 is 60.8 TWD — it has decreased by −1.29% in the past 24 hours. Watch TSH BIOPHARM CORPORATION LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TSH BIOPHARM CORPORATION LIMITED stocks are traded under the ticker 8432.
8432 stock has risen by 0.49% compared to the previous week, the month change is a −5.43% fall, over the last year TSH BIOPHARM CORPORATION LIMITED has showed a 19.92% increase.
We've gathered analysts' opinions on TSH BIOPHARM CORPORATION LIMITED future price: according to them, 8432 price has a max estimate of 68.00 TWD and a min estimate of 68.00 TWD. Watch 8432 chart and read a more detailed TSH BIOPHARM CORPORATION LIMITED stock forecast: see what analysts think of TSH BIOPHARM CORPORATION LIMITED and suggest that you do with its stocks.
8432 reached its all-time high on Mar 26, 2012 with the price of 116.1 TWD, and its all-time low was 35.0 TWD and was reached on Aug 25, 2015. View more price dynamics on 8432 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
8432 stock is 2.16% volatile and has beta coefficient of 0.45. Track TSH BIOPHARM CORPORATION LIMITED stock price on the chart and check out the list of the most volatile stocks — is TSH BIOPHARM CORPORATION LIMITED there?
Yes, you can track TSH BIOPHARM CORPORATION LIMITED financials in yearly and quarterly reports right on TradingView.
TSH BIOPHARM CORPORATION LIMITED is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
8432 net income for the last quarter is 48.54 M TWD, while the quarter before that showed 14.02 M TWD of net income which accounts for 246.31% change. Track more TSH BIOPHARM CORPORATION LIMITED financial stats to get the full picture.
Yes, 8432 dividends are paid annually. The last dividend per share was 1.28 TWD. As of today, Dividend Yield (TTM)% is 2.10%. Tracking TSH BIOPHARM CORPORATION LIMITED dividends might help you take more informed decisions.
TSH BIOPHARM CORPORATION LIMITED dividend yield was 2.54% in 2023, and payout ratio reached 75.21%. The year before the numbers were 3.36% and 95.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 68.00 employees. See our rating of the largest employees — is TSH BIOPHARM CORPORATION LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TSH BIOPHARM CORPORATION LIMITED EBITDA is 193.96 M TWD, and current EBITDA margin is 10.63%. See more stats in TSH BIOPHARM CORPORATION LIMITED financial statements.
Like other stocks, 8432 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TSH BIOPHARM CORPORATION LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TSH BIOPHARM CORPORATION LIMITED technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TSH BIOPHARM CORPORATION LIMITED stock shows the buy signal. See more of TSH BIOPHARM CORPORATION LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.